| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |